Comparison of two modes of ventilation in women undergoing laparoscopic surgery under General Anaesthesia

Comparison of Volume controlled ventilation and Pressure controlled ventilation in patients undergoing gynaecological laparoscopic surgery under General Anaesthesia using I-gel: A randomized controlled trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068717

Enrollment

Registered

2024-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: Z409- Encounter for prophylactic surgery, unspecified

Interventions

Intervention1: group V: MECHANICAL VENTILATION CONTINUED WITH VCV MODE. Intervention2: GROUP P: MECHANICAL VENTILATION WITH PCV MODE Intervention3: Volume Controlled Ventilation: Volume Controlled Ven

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients Undergoing Elective Gynaecological Laparascopic Surgeries 2.Patients in the age group of 18- 60 Years 3.Patients Belonging to ASA Physical Status 1 and 2 4.BMI Less Than and Equal to 30

Exclusion criteria

Exclusion criteria: 1.Any Contraindication for the use of Supraglottic Airway Devices 2.Patients Refusal for the study

Design outcomes

Primary

Measure	Time frame
Peak Airway Pressure after Initiation of Pneumoperitoneum Measured at Defined IntervalsTimepoint: T1.1o Minutes after Induction in Supine Position T2. After Creation of Pnemoperitoneum and achieving a stable End Tidal Carbon Dioxide Level of 35-40mm of hg for 5 Minutes T3.15 Minutes After Pneumoperitoneum in the Trendelenburg Position T4.10 Minutes After Pneumoperitoneum Withdrawal in Supine Position	—

Measure

Time frame

Peak Airway Pressure after Initiation of Pneumoperitoneum Measured at Defined IntervalsTimepoint: T1.1o Minutes after Induction in Supine Position T2. After Creation of Pnemoperitoneum and achieving a stable End Tidal Carbon Dioxide Level of 35-40mm of hg for 5 Minutes T3.15 Minutes After Pneumoperitoneum in the Trendelenburg Position T4.10 Minutes After Pneumoperitoneum Withdrawal in Supine Position

—

Secondary

Measure	Time frame
1.Haemodynamic Changes (SBP,DBP,MAP AND HR ) at Defined Intervals 2.Respiratory Mechanics P Mean & Dynamic Compliance in both the Groups 3.Final Ventilator settings Expiratory Tidal Volume & Respiratory Rate Required to achieve a stable EtCo2 of 35-40 mm of hg 4.Incidence of sore throat in both Groups 5.I GEL Insertion Number of attempts & success rate of insertion in both the Groups 6.Oropharyngeal Leak Pressure Measured by closing the Expiratory Valve of Closed Circuit at fixed gas flow & noting the Equilibrium Airway PressureTimepoint: T1.10 Minutes after Induction in Supine Position T2.After Creation of Pneumoperitoneum & achieving a stable End Tidal carbon dioxide LEVEL OF 35 -40 mm of hg for 5 minutes. T3-15 Minutes After Pneumoperitoneum in the Trendelenburg P0sition T4-10 Minutes After Pneumoperitoneum Withdrawal in Supine Position	—

Measure

Time frame

1.Haemodynamic Changes (SBP,DBP,MAP AND HR ) at Defined Intervals 2.Respiratory Mechanics P Mean & Dynamic Compliance in both the Groups 3.Final Ventilator settings Expiratory Tidal Volume & Respiratory Rate Required to achieve a stable EtCo2 of 35-40 mm of hg 4.Incidence of sore throat in both Groups 5.I GEL Insertion Number of attempts & success rate of insertion in both the Groups 6.Oropharyngeal Leak Pressure Measured by closing the Expiratory Valve of Closed Circuit at fixed gas flow & noting the Equilibrium Airway PressureTimepoint: T1.10 Minutes after Induction in Supine Position T2.After Creation of Pneumoperitoneum & achieving a stable End Tidal carbon dioxide LEVEL OF 35 -40 mm of hg for 5 minutes. T3-15 Minutes After Pneumoperitoneum in the Trendelenburg P0sition T4-10 Minutes After Pneumoperitoneum Withdrawal in Supine Position

—

Countries

India

Contacts

Public ContactDr.Hemanth

Vijayanagar Institute of Medical Sciences,Rajiv Gandhi University of Health Sciences

halsanadu@gmail.com9980600724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026